{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T03:57:21Z","timestamp":1791863841583,"version":"4.3.4"},"reference-count":62,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Affective Disorders"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.jad.2025.02.012","type":"journal-article","created":{"date-parts":[[2025,2,10]],"date-time":"2025-02-10T19:06:10Z","timestamp":1739214370000},"page":"302-312","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Esketamine alleviates cognitive impairment signs induced by modified electroconvulsive therapy in a depression rat model via the KLF4\/p38 MAPK pathway"],"prefix":"10.1016","volume":"376","author":[{"given":"Xiaohui","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiwei","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huili","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiongmei","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiajia","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jad.2025.02.012_bb0005","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1186\/s12974-014-0151-1","article-title":"The common inflammatory etiology of depression and cognitive impairment: a therapeutic target","volume":"11","author":"Allison","year":"2014","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.jad.2025.02.012_bb0010","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.neubiorev.2018.12.002","article-title":"Chronic unpredictable mild stress for modeling depression in rodents: meta-analysis of model reliability","volume":"99","author":"Antoniuk","year":"2019","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.jad.2025.02.012_bb0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.115921","article-title":"Cryptotanshinone regulates gut microbiota and PI3K-AKT pathway in rats to alleviate CUMS induced depressive symptoms","volume":"169","author":"Bian","year":"2023","journal-title":"Biomed. Pharmacother."},{"issue":"10","key":"10.1016\/j.jad.2025.02.012_bb0020","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0165392","article-title":"Anterograde amnesia during electroconvulsive therapy: a prospective pilot-study in patients with major depressive disorder","volume":"11","author":"Boere","year":"2016","journal-title":"PLoS One"},{"issue":"10194","key":"10.1016\/j.jad.2025.02.012_bb0025","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/S0140-6736(19)30934-1","article-title":"New WHO prevalence estimates of mental disorders in conflict settings: a systematic review and meta-analysis","volume":"394","author":"Charlson","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.jad.2025.02.012_bb0030","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.904005","article-title":"Effects of modified electroconvulsive therapy on serum cortisol, nesfatin-1, and pro-inflammatory cytokine levels in elderly patients with treatment-resistant depression","volume":"13","author":"Dai","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"2","key":"10.1016\/j.jad.2025.02.012_bb0035","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1001\/jamapsychiatry.2017.3739","article-title":"Efficacy and safety of intranasal esketamine adjunctive to oral antidepressant therapy in treatment-resistant depression: a randomized clinical trial","volume":"75","author":"Daly","year":"2018","journal-title":"JAMA Psychiatry"},{"issue":"3","key":"10.1016\/j.jad.2025.02.012_bb0040","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1038\/s41380-021-01380-y","article-title":"Electroconvulsive therapy, electric field, neuroplasticity, and clinical outcomes","volume":"27","author":"Deng","year":"2022","journal-title":"Mol. Psychiatry"},{"issue":"3","key":"10.1016\/j.jad.2025.02.012_bb0045","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1016\/j.ymthe.2021.11.006","article-title":"Microglia secrete miR-146a-5p-containing exosomes to regulate neurogenesis in depression","volume":"30","author":"Fan","year":"2022","journal-title":"Mol. Ther."},{"issue":"1","key":"10.1016\/j.jad.2025.02.012_bb0050","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s13195-020-00617-2","article-title":"A selective p38\u03b1\/\u03b2 MAPK inhibitor alleviates neuropathology and cognitive impairment, and modulates microglia function in 5XFAD mouse","volume":"12","author":"Gee","year":"2020","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.jad.2025.02.012_bb0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1146\/annurev-clinpsy-050817-084811","article-title":"Risk factors for depression: an autobiographical review","volume":"14","author":"Hammen","year":"2018","journal-title":"Annu. Rev. Clin. Psychol."},{"issue":"6","key":"10.1016\/j.jad.2025.02.012_bb0060","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1111\/fcp.12567","article-title":"Novel potential of metformin on valproic acid-induced autism spectrum disorder in rats: involvement of antioxidant defence system","volume":"34","author":"Ishola","year":"2020","journal-title":"Fundam. Clin. Pharmacol."},{"key":"10.1016\/j.jad.2025.02.012_bb0065","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.pnpbp.2018.09.009","article-title":"Insular changes induced by electroconvulsive therapy response to symptom improvements in schizophrenia","volume":"89","author":"Jiang","year":"2019","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"issue":"4","key":"10.1016\/j.jad.2025.02.012_bb0070","doi-asserted-by":"crossref","DOI":"10.1111\/appy.12411","article-title":"Efficacy and safety of modified electroconvulsive therapy for the refractory depression in older patients","volume":"12","author":"Jiang","year":"2020","journal-title":"Asia Pac. Psychiatry"},{"key":"10.1016\/j.jad.2025.02.012_bb0075","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2023.1141339","article-title":"Porphyromonas gingivalis-induced periodontitis could contribute to cognitive impairment in Sprague-Dawley rats via the P38 MAPK signaling pathway","volume":"17","author":"Jin","year":"2023","journal-title":"Front. Cell. Neurosci."},{"issue":"4","key":"10.1016\/j.jad.2025.02.012_bb0080","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.biopsych.2015.02.029","article-title":"Structural plasticity of the hippocampus and amygdala induced by electroconvulsive therapy in major depression","volume":"79","author":"Joshi","year":"2016","journal-title":"Biol. Psychiatry"},{"issue":"2","key":"10.1016\/j.jad.2025.02.012_bb0085","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1002\/cpt.2024","article-title":"Benefit-risk assessment of esketamine nasal spray vs. placebo in treatment-resistant depression","volume":"109","author":"Katz","year":"2021","journal-title":"Clin. Pharmacol. Ther."},{"issue":"2","key":"10.1016\/j.jad.2025.02.012_bb0090","article-title":"Exploring esketamine\u2019s therapeutic outcomes as an FDA-designated breakthrough for treatment-resistant depression and major depressive disorder with suicidal intent: a narrative review","volume":"16","author":"Kumari","year":"2024","journal-title":"Cureus"},{"issue":"1","key":"10.1016\/j.jad.2025.02.012_bb0095","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/s13034-023-00647-2","article-title":"Short-term cognitive effects of repeated-dose esketamine in adolescents with major depressive disorder and suicidal ideation: a randomized controlled trial","volume":"17","author":"Lan","year":"2023","journal-title":"Child Adolesc. Psychiatry Ment. Health"},{"issue":"2","key":"10.1016\/j.jad.2025.02.012_bb0100","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1034\/j.1399-5618.2002.01144.x","article-title":"Stress and depression: possible links to neuron death in the hippocampus","volume":"4","author":"Lee","year":"2002","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.jad.2025.02.012_bb0105","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.brainresbull.2022.07.004","article-title":"Esketamine alleviates postoperative cognitive decline via stimulator of interferon genes\/TANK-binding kinase 1 signaling pathway in aged rats","volume":"187","author":"Li","year":"2022","journal-title":"Brain Res. Bull."},{"issue":"19","key":"10.1016\/j.jad.2025.02.012_bb0110","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1056\/NEJMct075234","article-title":"Electroconvulsive therapy for depression","volume":"357","author":"Lisanby","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jad.2025.02.012_bb0115","first-page":"1847","article-title":"Propofol prevents electroconvulsive-shock-induced memory impairment through regulation of hippocampal synaptic plasticity in a rat model of depression","volume":"10","author":"Luo","year":"2014","journal-title":"Neuropsychiatr. Dis. Treat."},{"issue":"5","key":"10.1016\/j.jad.2025.02.012_bb0120","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1111\/acps.13492","article-title":"A systematic review of modified electroconvulsive therapy (ECT) to treat delirium","volume":"147","author":"Lupke","year":"2023","journal-title":"Acta Psychiatr. Scand."},{"issue":"Pt A","key":"10.1016\/j.jad.2025.02.012_bb0125","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.jad.2021.10.052","article-title":"Evaluating maintenance electroconvulsive therapy in Bipolar Disorders: 3-year mirror-image study","volume":"298","author":"Madero","year":"2022","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2025.02.012_bb0130","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1146\/annurev-neuro-090919-022842","article-title":"Synaptic plasticity forms and functions","volume":"43","author":"Magee","year":"2020","journal-title":"Annu. Rev. Neurosci."},{"issue":"10371","key":"10.1016\/j.jad.2025.02.012_bb0135","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0140-6736(22)02080-3","article-title":"Novel and emerging treatments for major depression","volume":"401","author":"Marwaha","year":"2023","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.jad.2025.02.012_bb0140","doi-asserted-by":"crossref","first-page":"Itc65","DOI":"10.7326\/AITC202105180","article-title":"Depression","volume":"174","author":"McCarron","year":"2021","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.jad.2025.02.012_bb0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2019.109489","article-title":"CTRP3 acts as a novel regulator in depressive-like behavior associated inflammation and apoptosis by meditating p38 and JNK MAPK signaling","volume":"120","author":"Meng","year":"2019","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.jad.2025.02.012_bb0150","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1146\/annurev-clinpsy-072220-021440","article-title":"Major depression and its recurrences: life course matters","volume":"18","author":"Monroe","year":"2022","journal-title":"Annu. Rev. Clin. Psychol."},{"issue":"4","key":"10.1016\/j.jad.2025.02.012_bb0155","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1007\/s00213-018-4828-5","article-title":"Effect of intranasal esketamine on cognitive functioning in healthy participants: a randomized, double-blind, placebo-controlled study","volume":"235","author":"Morrison","year":"2018","journal-title":"Psychopharmacology"},{"issue":"8","key":"10.1016\/j.jad.2025.02.012_bb0160","article-title":"SkQ1 suppresses the p38 MAPK signaling pathway involved in Alzheimer\u2019s disease-like pathology in OXYS rats","volume":"9","author":"Muraleva","year":"2020","journal-title":"Antioxidants (Basel)"},{"key":"10.1016\/j.jad.2025.02.012_bb0165","article-title":"Comparative efficacy and acceptability of non-surgical brain stimulation for the acute treatment of major depressive episodes in adults: systematic review and network meta-analysis","volume":"364","author":"Mutz","year":"2019","journal-title":"Bmj"},{"issue":"4","key":"10.1016\/j.jad.2025.02.012_bb0170","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1097\/ACO.0000000000001279","article-title":"Electroconvulsive therapy: recent advances and anesthetic considerations","volume":"36","author":"Ninke","year":"2023","journal-title":"Curr. Opin. Anaesthesiol."},{"issue":"4","key":"10.1016\/j.jad.2025.02.012_bb0175","doi-asserted-by":"crossref","first-page":"532","DOI":"10.4306\/pi.2015.12.4.532","article-title":"Increases in iPS transcription factor (Oct4, Sox2, c-Myc, and Klf4) gene expression after modified electroconvulsive therapy","volume":"12","author":"Nishiguchi","year":"2015","journal-title":"Psychiatry Investig."},{"key":"10.1016\/j.jad.2025.02.012_bb0180","author":"Organization, W.H"},{"key":"10.1016\/j.jad.2025.02.012_bb0185","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.bbi.2024.03.014","article-title":"Cognitive and inflammatory heterogeneity in severe mental illness: translating findings from blood to brain","volume":"118","author":"S\u00e6ther","year":"2024","journal-title":"Brain Behav. Immun."},{"issue":"6","key":"10.1016\/j.jad.2025.02.012_bb0190","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1038\/mp.2015.69","article-title":"Subcortical brain alterations in major depressive disorder: findings from the ENIGMA Major Depressive Disorder working group","volume":"21","author":"Schmaal","year":"2016","journal-title":"Mol. Psychiatry"},{"issue":"10","key":"10.1016\/j.jad.2025.02.012_bb0195","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1038\/mp.2016.118","article-title":"Cellular and molecular basis for stress-induced depression","volume":"22","author":"Seo","year":"2017","journal-title":"Mol. Psychiatry"},{"issue":"3","key":"10.1016\/j.jad.2025.02.012_bb0200","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1037\/a0035302","article-title":"From stress to inflammation and major depressive disorder: a social signal transduction theory of depression","volume":"140","author":"Slavich","year":"2014","journal-title":"Psychol. Bull."},{"issue":"7526","key":"10.1016\/j.jad.2025.02.012_bb0205","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/515180a","article-title":"Mental health: a world of depression","volume":"515","author":"Smith","year":"2014","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.jad.2025.02.012_bb0210","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1097\/HRP.0000000000000312","article-title":"Neurocognitive effects of ketamine and esketamine for treatment-resistant major depressive disorder: a systematic review","volume":"29","author":"Souza-Marques","year":"2021","journal-title":"Harv. Rev. Psychiatry"},{"issue":"11","key":"10.1016\/j.jad.2025.02.012_bb0215","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.13m08538","article-title":"Efficacy and cognitive side effects after brief pulse and ultrabrief pulse right unilateral electroconvulsive therapy for major depression: a randomized, double-blind, controlled study","volume":"74","author":"Spaans","year":"2013","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2025.02.012_bb0220","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.jpsychires.2014.02.007","article-title":"A new method to model electroconvulsive therapy in rats with increased construct validity and enhanced translational value","volume":"53","author":"Theilmann","year":"2014","journal-title":"J. Psychiatr. Res."},{"issue":"3","key":"10.1016\/j.jad.2025.02.012_bb0225","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1007\/s00406-020-01128-9","article-title":"Inflammatory cytokines derived from peripheral blood contribute to the modified electroconvulsive therapy-induced cognitive deficits in major depressive disorder","volume":"271","author":"Tian","year":"2021","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.jad.2025.02.012_bb0230","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.euroneuro.2021.04.023","article-title":"Comparative outcomes in electroconvulsive therapy (ECT): a naturalistic comparison between outcomes in psychosis, mania, depression, psychotic depression and catatonia","volume":"51","author":"Tor","year":"2021","journal-title":"Eur. Neuropsychopharmacol."},{"issue":"4","key":"10.1016\/j.jad.2025.02.012_bb0235","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1111\/acps.13397","article-title":"Pharmacological interventions to diminish cognitive side effects of electroconvulsive therapy: a systematic review and meta-analysis","volume":"145","author":"Verdijk","year":"2022","journal-title":"Acta Psychiatr. Scand."},{"issue":"1","key":"10.1016\/j.jad.2025.02.012_bb0240","doi-asserted-by":"crossref","first-page":"71","DOI":"10.2174\/1570159X14666160202121111","article-title":"Synaptic plasticity, metaplasticity and depression","volume":"15","author":"Vose","year":"2017","journal-title":"Curr. Neuropharmacol."},{"issue":"2","key":"10.1016\/j.jad.2025.02.012_bb0245","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.brs.2018.11.006","article-title":"ECT-induced brain plasticity correlates with positive symptom improvement in schizophrenia by voxel-based morphometry analysis of grey matter","volume":"12","author":"Wang","year":"2019","journal-title":"Brain Stimul."},{"issue":"3","key":"10.1016\/j.jad.2025.02.012_bb0250","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.jgr.2021.03.005","article-title":"Antidepressant-like effect of ginsenoside Rb1 on potentiating synaptic plasticity via the miR-134-mediated BDNF signaling pathway in a mouse model of chronic stress-induced depression","volume":"46","author":"Wang","year":"2022","journal-title":"J. Ginseng Res."},{"issue":"10","key":"10.1016\/j.jad.2025.02.012_bb0255","doi-asserted-by":"crossref","first-page":"3178","DOI":"10.1007\/s11064-022-03672-3","article-title":"The protective effect of Palmatine on depressive like behavior by modulating microglia polarization in LPS-induced mice","volume":"47","author":"Wang","year":"2022","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.jad.2025.02.012_bb0260","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jad.2022.11.018","article-title":"The protective role of hippocampal LRP1 knockdown involves synaptic plasticity through the promoting microtubule dynamics and activation of Akt\/GSK-3\u03b2 pathway in depressive rats","volume":"322","author":"Wang","year":"2023","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2025.02.012_bb0265","doi-asserted-by":"crossref","first-page":"5680","DOI":"10.1007\/s12035-023-03860-4","article-title":"Esketamine prevents postoperative emotional and cognitive dysfunction by suppressing microglial M1 polarization and regulating the BDNF-TrkB pathway in ageing rats with preoperative sleep disturbance","volume":"61","author":"Wen","year":"2024","journal-title":"Mol. Neurobiol."},{"issue":"6","key":"10.1016\/j.jad.2025.02.012_bb0270","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1038\/s41380-023-02024-z","article-title":"Friend or foe: role of pathological tau in neuronal death","volume":"28","author":"Wu","year":"2023","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.jad.2025.02.012_bb0275","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2023.111284","article-title":"Esketamine mitigates cognitive impairment following exposure to LPS by modulating the intestinal flora\/subdiaphragmatic vagus nerve\/spleen axis","volume":"126","author":"Wu","year":"2024","journal-title":"Int. Immunopharmacol."},{"issue":"10","key":"10.1016\/j.jad.2025.02.012_bb0280","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1080\/17425255.2019.1669560","article-title":"Pharmacokinetic considerations for current state-of-the-art antidepressants","volume":"15","author":"Wyska","year":"2019","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"issue":"1","key":"10.1016\/j.jad.2025.02.012_bb0285","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1515\/tnsci-2022-0251","article-title":"Esketamine improves propofol-induced brain injury and cognitive impairment in rats","volume":"13","author":"Xu","year":"2022","journal-title":"Transl. Neurosci."},{"issue":"4","key":"10.1016\/j.jad.2025.02.012_bb0290","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1038\/s41419-023-05800-5","article-title":"Upregulation of KLK8 contributes to CUMS-induced hippocampal neuronal apoptosis by cleaving NCAM1","volume":"14","author":"Xu","year":"2023","journal-title":"Cell Death Dis."},{"issue":"1","key":"10.1016\/j.jad.2025.02.012_bb0295","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1002\/kjm2.12778","article-title":"Role and mechanism of esketamine in improving postoperative cognitive dysfunction in aged mice through the TLR4\/MyD88\/p38 MAPK pathway","volume":"40","author":"Xu","year":"2024","journal-title":"Kaohsiung J. Med. Sci."},{"issue":"8","key":"10.1016\/j.jad.2025.02.012_bb0300","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1038\/s41386-023-01577-5","article-title":"Long-term safety and maintenance of response with esketamine nasal spray in participants with treatment-resistant depression: interim results of the SUSTAIN-3 study","volume":"48","author":"Zaki","year":"2023","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.jad.2025.02.012_bb0305","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.ajp.2019.07.045","article-title":"Cognitive decline after electroconvulsive therapy, based on psychiatric disorders","volume":"44","author":"Zandifar","year":"2019","journal-title":"Asian J. Psychiatr."},{"key":"10.1016\/j.jad.2025.02.012_bb0310","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.jad.2024.08.123","article-title":"Electroconvulsive therapy combined with esketamine improved depression through PI3K\/AKT\/GLT-1 pathway","volume":"368","author":"Zang","year":"2024","journal-title":"J. Affect. Disord."}],"container-title":["Journal of Affective Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032725002009?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032725002009?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T09:42:25Z","timestamp":1762249345000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165032725002009"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":62,"alternative-id":["S0165032725002009"],"URL":"https:\/\/doi.org\/10.1016\/j.jad.2025.02.012","relation":{},"ISSN":["0165-0327"],"issn-type":[{"value":"0165-0327","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Esketamine alleviates cognitive impairment signs induced by modified electroconvulsive therapy in a depression rat model via the KLF4\/p38 MAPK pathway","name":"articletitle","label":"Article Title"},{"value":"Journal of Affective Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jad.2025.02.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}